B1F International Conference Hall,
CHA Bio Complex
- 등록 마감일 2023년 10월 23일(월)
- 문의 031-881-7371
GFFM 2023에 여러분을 초대합니다!
이번 행사는 세포·유전자 치료 (CGT) 분야를 선도하는 연구자분들을 한자리에 모시고 최신 동향과 연구결과를 공유하며, 네트워킹과 상호 협력을 증진하는데 그 목적이 있습니다. CGT는 최근 의료 분야에서 큰 관심을 받는 분야 중 하나입니다.
CGT 분야의 괄목할 만한 발전은 기존의 치료 방법이 한계에 부딪힌 다양한 질환 분야에 새로운 해결책을 제시하고 있습니다.
세포·유전자 치료 분야의 석학들과 다양한 주제를 놓고 강연과 토론을 하고 네트워킹을 하는 이번 포럼이 새로운 협력의 장이 되고 미래의학의 발전에 기여하는 촉매제 역할을 하기를 기대합니다.
감사합니다.
차종합연구원장
윤호섭 드림
Welcome to the Global Forum on Future Medicine 2023!
We are delighted to extend our warmest invitation to you for the Global Forum on Future Medicine 2023 (GFFM 2023). This event will take place at the state-of-the-art CHA Bio Complex in Pangyo, Korea.
It brings together leading scholars, pioneers, and visionaries in cell and gene therapies (CGT).
Recent progresses made in CGT are advancing innovative therapies in medicine. To this end, we have curated distinguished speakers who will share with us their invaluable insights and seminal research findings, thereby paving the way for the future of regenerative medicine.
This event promises to offer a rich and diverse program to explore the latest cutting-edge cell and gene therapy research breakthroughs. It fosters knowledge exchange and collaborations with renowned experts, providing opportunities to engage in thought-provoking discussions on the challenges and opportunities in this rapidly advancing field. Beyond the intellectual stimulation, we also aim to create an environment conducive to collaboration and networking. Through engaging in fruitful conversations and building relationships with fellow participants, we hope to lay the foundation for future collaborations and groundbreaking research projects that will shape the research landscape for unmet medical needs.
We look forward to welcoming you to the GFFM 2023.
Sincerely,
Ho Sup Yoon
Professor & President CHA Advanced Research Institute일시 | 2023.10.27(금), 08:00~18:00 |
---|---|
장소 | 차바이오컴플렉스 국제회의실 |
주최 | 차바이오그룹 |
경기도 성남시 분당구 판교로 335 차바이오컴플렉스 |
Registration | International Conference Hall (Entrance) |
Opening ceremony
|
Chairpersons
|
PL1 : Stem cell research and its clinical translation |
Hiromitsu Nakauchi Stanford Univ., USA
|
Generation of haploid genomes by SCNT |
Shoukhrat Mitalipov Oregon Health &
Science Univ., USA |
Reconstitution of reproductive organs accompanied by germ cell development and sex determination |
Katsuhiko Hayashi Osaka University, JP
|
Prevention of ovarian aging using mesenchymal progenitor cells derived from SCNT-PSCs |
Dong Ryul Lee CHA Univ., KR
|
Break |
Chairpersons
|
Retinal cell therapy using iPS cells |
Masayo Takahashi Vision Care, JP
|
Pluripotent stem cell derived RPE for treatment of macular degeneration |
Youngje Sung CHA Bundang Medical
Center, KR |
Stem cell therapy for Huntington’s disease |
Jihwan Song CHA Univ., KR
|
Organoid-based regenerative medicine |
Jongman Yoo CHA Univ., KR
|
Lunch |
Chairpersons
|
PL2: iPSC-based regenerative therapy for spinal cord Injury |
Hideyuki Okano Keio Univ., JP
|
Application of stem cells in the repair of intervertebral disc degeneration |
Inbo Han CHA Bundang Medical
Center, KR |
PL3: Stem cell therapy for Parkinson’s disease |
Kwang-Soo Kim Harvard Univ., USA
|
The treatment of Parkinson's disease with fetal midbrain precursor cells |
Joo Pyung Kim CHA Bundang Medical
Center, KR |
Break |
Chairpersons
|
Expanding AAV-mediated gene therapy for rare neurological disorders |
Steven Gray UT Southwestern, USA
|
Cellular and immunotherapy in children with cancer and blood disorders |
Andrew Koh UT Southwestern, USA
|
T Cell Therapy : A tumor-agnostic, patient-centric approach to personalized cancer treatment |
Cassian Yee MD Anderson Cancer
Center, USA |
Autologous NK immunotherapy for recurrent glioblastoma |
Jae Joon Lim CHA Bundang Medical
Center, KR |
Break |
Chairpersons
|
Current status of regulations and development supports for advanced biopharmaceuticals by the Korean Ministry of Food and Drug Safety (MFDS) |
Mira Choi MFDS, KR
|
Regulatory framework and current status of regenerative medicine in Japan |
Shinichi Noda PMDA, JP
|
A unique setting of open innovation programs at iPARK |
Yasushi Kajii Takeda, JP
|
Creating and fostering life science ecosystem in Japan |
Ikuo Hayashi LINK-J, JP
|
The Boston bio cluster and its successful partnerships |
Jung-Hoon Woo BW Biomed LLC, USA
|
Concluding Remarks |
Yun Jeong Song Matica Biotechnology, USA
|